Rooted in nature and driven by three integrated technology platforms, AKTINPHARM® is dedicated to delivering comprehensive drug R&D and manufacturing services (CRDMO) to global pharmaceutical and biopharmaceutical companies.
We deeply support innovative drug R&D enterprises and Marketing Authorization Holders (MAHs) by offering tailored
R&D (CRO) and Manufacturing (CMO) solutions spanning early clinical stages (covering hit and lead compound research) to commercial drug production.
Products & Solutions
Plant power, health within reach.
AKTINPHARM® Pharmaceutical
Product Center
AKTINPHARM® Pharmaceutical Solutions
Drug Research & Development
Drug Discovery
Natural Compounds & Synthetic Chemistry & Custom synthesis services & Target compound screening & Lead Compound Optimization
Learn More 
Quality Research & Analysis Services
Based on the expertise of our analytical research and development, QC and QA teams, we provide quality research and stability study services for active pharmaceutical ingredients (APIs), formulations, intermediates, and registered raw materials that meet regulatory submission requirements.
Learn More 
APIs CRDMO
We provide process route design, development and optimization for innovative and generic drugs, and provide professional services in quality research, process validation, product life cycle management and process safety assessment based on the QbD concept.
Learn More 
Drug Development CRDMO
Based on the formulation process development and production technology platform, and in collaboration with CDMO for APIs, we build an efficient formulation service platform, including the whole process service from pre-prescription to commercial of formulation development and production.
Learn More 
CRDMO for ADC drugs
Aktin Chemicals, Inc. offer comprehensive ADC drug R&D and manufacturing services (CRDMO) spanning early clinical stages to commercial manufacturing, supporting a wide range of conjugated drug modalities (XDCs), including antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and other innovative bioconjugates.
Learn More 
Registration and Application Services
We have a dedicated drug regulatory team that offers clients services for clinical trial applications (IND/CTA) at different stages (P1, P2, P3), new drug marketing authorization applications (NDA/MAA), generic drug marketing authorization applications (ANDA), and product marketing maintenance, including services for product changes, annual reports, and re-registration.
Learn More 
